WebMD Health Price / Sales Ratio: 2.76
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
WBMD Price / Sales Ratio Rankings
| Overall | 24th percentile | 3303 of 4365 |
| Sector | 26th percentile | 606 of 826 in Technology |
| Industry | 45th percentile | 6 of 11 in Healthcare Information Services |
WBMD Price / Sales Ratio Range, Past 5 Years
| Minimum | 8.99 | Sep 2006 |
| Maximum | 13.54 | Jun 2006 |
| Average | 10.90 |
About Price to Sales Ratio
The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.
An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.
Learn More
You may also be interested in these WBMD related companies
WBMD News
WebMD to Host Town Hall on Children's Health with First Lady Michelle Obama
Feb 08, 12:00PM PR Newswire
Feb 08, 12:00PM PR Newswire
$WBMD Insider Buy: $1.7M of stock bought by Carl Icahn on January 19, 2012 http://stks.co/24W4
about 19 days ago by MarketBrief
about 19 days ago by MarketBrief
$WBMD Insider Buy: $1.7M of stock bought by Carl Icahn on January 19, 2012 http://stks.co/23Fm
about 20 days ago by MarketBrief
about 20 days ago by MarketBrief
Is it me or are there more strategic reviews than usual ending in no sale? $IDCC, $WBMD, and so on...
about 20 days ago by ActAccordingly
about 20 days ago by ActAccordingly
WebMD Says Talks on Possible Sale Never Led to Any Formal Proposals http://stks.co/20sQ $wbmd
about 23 days ago by DedicatedShort
about 23 days ago by DedicatedShort
Interest in $WBMD from would-be buyers also apparently waned before it preannounced and its CEO resigned. (3/3) http://dcl.sr/Zo
about 24 days ago by ScottKesslerSPCIQ
about 24 days ago by ScottKesslerSPCIQ
We don’t see as realistic Carl Icahn’s suggestion for $WBMD to buy back $1 billion in shares for up to $30/share. (2/3) http://dcl.sr/Zn
about 24 days ago by ScottKesslerSPCIQ
about 24 days ago by ScottKesslerSPCIQ
Today we reiterated our Sell opinion on $WBMD, reflecting our view of the company’s continuing challenges. (1/3) http://dcl.sr/Zm
about 24 days ago by ScottKesslerSPCIQ
about 24 days ago by ScottKesslerSPCIQ
$WBMD I guess Carls team didn't see that memo about nobody wanting to buy it. hmm either way she's going back up !
about 24 days ago by professorkev
about 24 days ago by professorkev
Interesting that $WBMD went out of its way to mention that Softbank was never involved in the potential sales process.
about 24 days ago by ActAccordingly
about 24 days ago by ActAccordingly
WebMD (WBMD) Discloses Info on Process of Considering Strategic Alternatives in 2011
Jan 19, 8:04AM Street Insider
Jan 19, 8:04AM Street Insider
RT @Street_Insider $WBMD shares up 3+%; Icahn lifts stake from 9.99% to 11.64%, recommends $1B buyback at $30/share
about 24 days ago by katetrades
about 24 days ago by katetrades
Going activist #Icahn Raises Stake in WebMD from 9.99% to 11.64% http://stks.co/1z0z $WBMD
about 24 days ago by valuewalk
about 24 days ago by valuewalk
RT @TradersColiseum - Watch List Bottom performers - $TZOO, $WBMD, $CJES, $LF, $MTG
about 24 days ago by WorldJazz59
about 24 days ago by WorldJazz59
Roth Capital Cuts WebMD (WBMD) to Neutral as Co. Ends Sale Talks, CEO Resigns
Jan 11, 12:28PM Street Insider
Jan 11, 12:28PM Street Insider
Wells Fargo Downgrades WebMD Health Corp. (WBMD) to Market Perform; Outlook Goes From Bad To Worse
Jan 11, 7:31AM Street Insider
Jan 11, 7:31AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| WBMD | 27.09 | -0.51 | -1.85% | 1.59B |
| PG | 63.88 | -0.16 | -0.25% | 175.75B |
| KFT | 38.58 | -0.06 | -0.16% | 68.14B |
| IBKR | 15.61 | 0.30 | 1.96% | 711.35M |
| BIDU | 136.59 | 1.15 | 0.85% | 37.00B |
| TD | 78.52 | -0.77 | -0.97% | 69.79B |
| BMY | 31.90 | -0.09 | -0.28% | 54.06B |
| KFFB | 9.07 | -0.15 | -1.63% | 70.20M |
| TZOO | 25.60 | -0.66 | -2.51% | 408.58M |
| BK | 21.42 | -0.36 | -1.65% | 25.97B |
